Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Monte Rosa Therapeutics (GLUE)

Annual Return

Over the past 3 years, GLUE has had an average annual return of +32.96%, outperforming the benchmark SPY, which returned +22.77% annual.

Since Jun 24, 2021, GLUE has had an average annual return of -3.52%, underperforming the benchmark SPY, which returned +13.96% annual.

202620252024202320222021
+13.14%+125.91%+22.83%-25.74%-62.73%-3.59%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+30.87%-13.49%-7.33%+16.42%+2.92%-9.99%+13.14%
2025-4.06%-17.40%-15.63%+5.80%-14.84%+7.85%+9.77%-3.04%+54.41%+73.39%+25.84%-3.04%+125.91%
2024-6.30%+19.56%+11.38%-24.54%-22.57%-9.20%+20.84%+36.50%-14.11%+60.39%+21.88%-33.00%+22.83%
2023-2.76%-17.83%+28.11%-41.71%+62.50%-7.18%+3.22%-16.99%-18.37%-29.05%-8.79%+82.24%-25.74%
2022-38.00%+13.28%-2.24%-22.25%-28.99%+24.96%-6.22%-12.68%+3.16%+12.63%-7.83%-10.26%-62.73%
2021+7.18%+8.01%+45.56%-37.58%+5.26%-17.31%+5.31%-3.59%

Drawdown analysis of Monte Rosa Therapeutics (GLUE)

The maximum drawdown for the GLUE was -94.08%, occurring on Oct 25, 2023. This drawdown has not yet recovered.

The current GLUE drawdown is -57.97%.

Since Jun 24, 2021 GLUE has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-94.08%Sep 3, 2021538Oct 25, 2023OngoingOngoingOngoing
-18.11%Jun 30, 20218Jul 13, 20218Jul 23, 202116
-10.95%Jun 24, 20211Jun 25, 20213Jun 30, 20214
-7.82%Aug 26, 20213Aug 31, 20212Sep 2, 20215
-4.70%Aug 10, 20212Aug 12, 20212Aug 16, 20214
-4.56%Aug 16, 20211Aug 17, 20213Aug 20, 20214
-4.23%Jul 23, 20212Jul 27, 20212Jul 29, 20214
-2.88%Aug 5, 20211Aug 6, 20211Aug 9, 20212